Many Young Children with Autism Who Use Psychotropic Medication Do Not Receive Behavior Therapy: A Multisite Case-Control Study (original) (raw)
Therapy and Psychotropic Medication Use in Young Children With Autism Spectrum Disorder
Abbas Jawad
Pediatrics, 2020
View PDFchevron_right
Use of Psychotropic Medication in Children and Adolescents With Autism Spectrum Disorders
evdokia anagnostou
Pediatrics, 2012
View PDFchevron_right
A Longitudinal Investigation of Psychotropic and Non-Psychotropic Medication Use Among Adolescents and Adults with Autism Spectrum Disorders
Michael Aman
Journal of Autism and Developmental Disorders, 2009
View PDFchevron_right
Prevalence and Patterns of Use of Psychoactive Medicines in Individuals with Autism in the Autism Society of North Carolina
Michael Aman
Journal of Child and Adolescent Psychopharmacology, 2002
View PDFchevron_right
Psychotropic Drug Use in Children with Autism Spectrum Disorder Admitted to a Training and Research Hospital Outpatient Clinic: A Retrospective Cross-Sectional Study
Yusuf Gürel
Journal of Child Science, 2020
View PDFchevron_right
Psychotropic drug treatments for people with autism and other developmental disorders: a primer for practicing behavior analysts
Marc Weeden
Behavior analysis in practice, 2010
View PDFchevron_right
Prevalence and patterns of use of psychoactive medicines among individuals with autism in the Autism Society of Ohio
Michael Aman
Journal of autism and developmental disorders, 2003
View PDFchevron_right
Psychotropic Medication Use among Insured Children with Autism Spectrum Disorder
Frances Lynch
Journal of autism and developmental disorders, 2016
View PDFchevron_right
Pharmacotherapy in Autism Spectrum Disorder: How, When and Why
Francesca Felicia Operto
BRAIN. BROAD RESEARCH IN ARTIFICIAL INTELLIGENCE AND NEUROSCIENCE, 2020
View PDFchevron_right
Research Units of Pediatric Psychopharmacology (RUPP) autism network randomized clinical trial of parent training and medication: one-year follow-up
Naomi Swiezy
Journal of the American Academy of Child and Adolescent Psychiatry, 2012
View PDFchevron_right
Are there lessons to be learned from the prevailing patterns of psychotropic drug use in patients with autism spectrum disorder?
Gagan Joshi
Acta Psychiatrica Scandinavica
View PDFchevron_right
Overuse of psychotropic medications among children and adolescents with autism spectrum disorders: Perspective from a developing country
Amirhossein Memari
Research in Developmental Disabilities, 2012
View PDFchevron_right
Prevalence and Predictors of Psychotropic Use in Children with High-Functioning ASDs
Martin A Volker
Autism research and treatment, 2013
View PDFchevron_right
Behaviour Management Problems as Predictors of Psychotropic Medication and Use of Psychiatric Services in Adults with Autism
Elias Tsakanikos
Journal of Autism and Developmental Disorders, 2007
View PDFchevron_right
Psychotropic Medications Use among Children with Autism in Saudi Arabia
Shuliweeh Alenezi
Children
View PDFchevron_right
Psychotropic Medication Use for Adults with Autism Spectrum Disorder who Receive Services and Supports Through Adult Developmental Disability Services in the United States
Amy Hewitt
Journal of Autism and Developmental Disorders, 2019
View PDFchevron_right
Psychotropic Medication Prescription for Autism: Data Sources for Decision Making
Jacqueline D'Angelo
Advances in Neurodevelopmental Disorders, 2018
View PDFchevron_right
Assessment of Psychopathological Comorbidities in Children and Adolescents With Autism Spectrum Disorder Using the Child Behavior Checklist
Giovanni Valeri
Frontiers in Psychiatry, 2019
View PDFchevron_right
Unmet Need for Therapy Among Children with Autism Spectrum Disorder: Results from the 2005-2006 and 2009-2010 National Survey of Children with Special Health Care Needs
Shelly Lane
Maternal and child health journal, 2016
View PDFchevron_right
Assessment of the Utilization of Pharmacotherapy for Pediatrics with Autism Spectrum Disorder in Jeddah, KSA
Suzan Morsy
World Family Medicine Journal/Middle East Journal of Family Medicine, 2020
View PDFchevron_right
Practitioner’s review: medication for children and adolescents with autism spectrum disorder (ASD) and comorbid conditions
Christian Popow
neuropsychiatrie
View PDFchevron_right
Outcome for Children with Autism who Began Intensive Behavioral Treatment Between Ages 4 and 7: A Comparison Controlled Study
Sigmund Eldevik, Svein Eikeseth
Behavior Modification, 2007
View PDFchevron_right
Efficacy of Behavioral Interventions for Young Children with Autism Spectrum Disorders: Public Policy, the Evidence Base, and Implementation Parameters
Raymond Romanczyk
Review Journal of Autism and Developmental Disorders, 2014
View PDFchevron_right
Pharmacological treatments prescribed to people with autism spectrum disorder (ASD) in primary health care
Macey Murray
Psychopharmacology, 2014
View PDFchevron_right
Prescription Trends of Psychotropics in Children and Adolescents with Autism Based on Nationwide Health Insurance Data
hyejung chang
Journal of Korean medical science, 2017
View PDFchevron_right
Pharmacotherapy and Children With Autism Spectrum Disorder: A Tutorial for Speech-Language Pathologists
Trisha Self
Language, Speech, and Hearing Services in Schools, 2010
View PDFchevron_right
Using Participant Data to Extend the Evidence Base for Intensive Behavioral Intervention for Children With Autism
Sigmund Eldevik, Svein Eikeseth
American Journal on Intellectual and Developmental Disabilities, 2010
View PDFchevron_right
Parental reports on the use of treatments and therapies for children with autism spectrum disorders
Virginia Mackintosh
Research in Autism Spectrum Disorders, 2007
View PDFchevron_right
Psychotropic medication use and polypharmacy in children with autism spectrum disorders
Taylor Dennen
Child: Care, Health and Development, 2014
View PDFchevron_right
Neuropsychiatric profile and psychotropic medication use in adults with autism spectrum disorder: results from the Australian Longitudinal Study of Adults with Autism
Kitty-Rose Foley
BJPsych Open
View PDFchevron_right